To Assess the Influence of Aronox on Parameters Associated With Recovery Following Muscle Damaging Exercise

Launched by NORTHUMBRIA UNIVERSITY · Oct 2, 2018

Keywords

ClinConnect Summary

A randomized, double blind, counterbalanced, placebo controlled independent groups design. Prior to the visit, participants will be given a participant information sheet to inform of the procedure and requirements and undergo initial screening via email or telephone to ascertain suitability to participate. If interested parties wish to participate, then they will be invited for a familiarisation visit, where they will:

* Be provided with an overview of the protocol and given the opportunity to ask questions
* Complete a health and physical activity questionnaire to ascertain study suitabil...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Healthy men 18-35 years of age
• • Free from musculoskeletal injury
• • Do not participate in more than 4 hour of vigorous exercise per week
• • Not taking dietary supplement or pre workout supplements for at least 1 month prior to study start
• • Can abstain from other exercise for the duration of damage part of the study (4 days)
• • Willing to participate and adhere to the study protocol
• • Willing to limit berry and/or cherry intake to one portion per day
• • Not to change their dietary / workout habits throughout the study (apart from abstaining from exercise during the damage part of the study)
• • Able to understand the participant information, health screening questionnaire and the informed consent information
• • Willing to participate and sign the informed consent form
• Exclusion Criteria:
• • BMI ≥30
• • Taking any medication that might affect the outcome of the study, such as anti-inflammatory and immunosuppressant drugs
• • Performance enhancing drugs and recreational drugs
• • Orthopedic problems that include muscle tears that might affect ability to perform exercise
• • Subject has a significant history or current presence of treated or untreated cardiometabolic, gastrointestinal, bleeding disorder, diabetes mellitus, high blood pressure (BP) \[systolic BP\> 140 and/or diastolic BP\> 90\], thyroid disease, tachyarrhythmia, heart disease, kidney disease, or liver disease.
• • Subject currently suffers from a sleep disorder and/or has a known history of (or is currently being treated for) clinical depression, eating disorder(s) or any other psychiatric condition(s), which in the opinion of the investigator, might put the subject at risk and/or confound the results of the study.
• • Have a recent history of surgery that might affect physical performance
• • Current smoker
• • Significant recent or planned change in dietary habit
• • Have lost more than 6 kg in the past 6 months or planning to lose weight in the next month
• • Allergy to berries
• • Drinking more than 2 alcoholic beverages per day on average in a week (total 14 units)